Saeedeh Nabati

Saeedeh Nabati

Auto-generated profile, based on publicly available information

Saeedeh Nabati

Cell Death and Differentiation Signaling Research Lab, Clinical Biochemistry Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Immunology Letters
Verified
Journal Article
Closed access
SNSaeedeh Nabati
Saeedeh Nabati
GAG.R. Asadi
G.R. Asadi
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
GSGholamabbas Shahabinejad
Gholamabbas Shahabinejad
MRMohsen Rezaeian
Mohsen Rezaeian
DKDerek Kennedy
Derek Kennedy

28 June 2012 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
FAFariba Aminzadeh
Fariba Aminzadeh
ZGZohreh Ghorashi
Zohreh Ghorashi
SNSaeedeh Nabati
Saeedeh Nabati
MGMohsen Ghasemshirazi
Mohsen Ghasemshirazi
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
GHGholamhossein Hassanshahi
Gholamhossein Hassanshahi

16 August 2020 in Nutrition and Cancer
Verified
Journal Article
Closed access
HGHossein Ghahremani
Hossein Ghahremani
SNSaeedeh Nabati
Saeedeh Nabati
HTHanieh Tahmori
Hanieh Tahmori
TPTahmineh Peirouvi
Tahmineh Peirouvi
MSMajid Sirati-Sabet
Majid Sirati-Sabet
SSSiamak Salami
Siamak Salami
The beneficial impacts of the ketogenic diet and metabolic reprograming were recently reported for ovarian cancer patients. In this study, the effects of glucose restriction with or without beta-hydroxybutyrate (bHB) enrichment were studied in drug-resistant CD133high A2780CP and CD133low SK-OV-3 ovarian cancer cells to scrutinize the impact of experimental ketosis on ATP production, epithelial to mesenchymal transition (EMT), and related signaling pathways including Wnt, Hippo, and Hedgehog. Cells were adapted and maintained for a month with restricted levels of glucose (250 mg/l) with or without the therapeutic concentration of bHB (5 mM). Quantitative PCR, Western blot analysis, flow cytometry, chemiluminescence, and wound healing assay were used in this study. Glucose restriction and bHB enrichment reduced the stemness marker and diminished In Vitro migration in both cell lines. Glucose restriction significantly reduced ATP levels in both cells, but bHB enrichment was partially compensated for the ATP levels solely in SK-OV-3 cells. Glucose restriction mainly inhibited the Wnt pathway in the CD133high A2780CP cells, but the Hedgehog pathway was the main target in CD133low SK-OV-3 cells. In Conclusion, Prior targeted evaluations of key genes' expression would help to predict the distinctive impacts of metabolic fuels and to optimize the efficacy of ketogenic diets.

1 September 2011 in Clinical Biochemistry
Verified
Journal Article
Closed access
EHEghbali Hadis
Eghbali Hadis
HMHosseini-Zijoud Seyyed Mostafa
Hosseini-Zijoud Seyyed Mostafa
NSNabati Saeedeh
Nabati Saeedeh
MMMahmoodi Mehdi
Mahmoodi Mehdi

1 September 2011 in Clinical Biochemistry
Verified
Journal Article
Closed access
ZHZijoud Seyyed Mostafa Hosseini
Zijoud Seyyed Mostafa Hosseini
JHJavad Hosseini
Javad Hosseini
SNSaeedeh Nabati
Saeedeh Nabati
GHGholamhossein Hasanshahi
Gholamhossein Hasanshahi
MMMehdi Mahmoodi
Mehdi Mahmoodi